Phase II study of continuous infusion fluorouracil with epirubicin and cisplatin in patients with metastatic and locally advanced breast cancer: an active new regimen.

Source:http://linkedlifedata.com/resource/pubmed/id/8201387

Download in:

View as

General Info

PMID
8201387